These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37184885)

  • 1. Molecular Generation with Reduced Labeling through Constraint Architecture.
    Wang J; Zeng Y; Sun H; Wang J; Wang X; Jin R; Wang M; Zhang X; Cao D; Chen X; Hsieh CY; Hou T
    J Chem Inf Model; 2023 Jun; 63(11):3319-3327. PubMed ID: 37184885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FSM-DDTR: End-to-end feedback strategy for multi-objective De Novo drug design using transformers.
    Monteiro NRC; Pereira TO; Machado ACD; Oliveira JL; Abbasi M; Arrais JP
    Comput Biol Med; 2023 Sep; 164():107285. PubMed ID: 37557054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generative machine learning for de novo drug discovery: A systematic review.
    Martinelli DD
    Comput Biol Med; 2022 Jun; 145():105403. PubMed ID: 35339849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive assessment of deep generative architectures for de novo drug design.
    Wang M; Sun H; Wang J; Pang J; Chai X; Xu L; Li H; Cao D; Hou T
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34929743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRELinker: A Graph-Based Generative Model for Molecular Linker Design with Reinforcement and Curriculum Learning.
    Zhang H; Huang J; Xie J; Huang W; Yang Y; Xu M; Lei J; Chen H
    J Chem Inf Model; 2024 Feb; 64(3):666-676. PubMed ID: 38241022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faster and more diverse de novo molecular optimization with double-loop reinforcement learning using augmented SMILES.
    Bjerrum EJ; Margreitter C; Blaschke T; Kolarova S; de Castro RL
    J Comput Aided Mol Des; 2023 Aug; 37(8):373-394. PubMed ID: 37329395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMGN: a conditional molecular generation net to design target-specific molecules with desired properties.
    Yang M; Sun H; Liu X; Xue X; Deng Y; Wang X
    Brief Bioinform; 2023 Jul; 24(4):. PubMed ID: 37193672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Training recurrent neural networks as generative neural networks for molecular structures: how does it impact drug discovery?
    D'Souza S; Kv P; Balaji S
    Expert Opin Drug Discov; 2022 Oct; 17(10):1071-1079. PubMed ID: 36216812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-content image generation for drug discovery using generative adversarial networks.
    Hussain S; Anees A; Das A; Nguyen BP; Marzuki M; Lin S; Wright G; Singhal A
    Neural Netw; 2020 Dec; 132():353-363. PubMed ID: 32977280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of reinforcement learning in transformer-based molecular design.
    He J; Tibo A; Janet JP; Nittinger E; Tyrchan C; Czechtizky W; Engkvist O
    J Cheminform; 2024 Aug; 16(1):95. PubMed ID: 39118113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DockingGA: enhancing targeted molecule generation using transformer neural network and genetic algorithm with docking simulation.
    Gao C; Bao W; Wang S; Zheng J; Wang L; Ren Y; Jiao L; Wang J; Wang X
    Brief Funct Genomics; 2024 Sep; 23(5):595-606. PubMed ID: 38582610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformer neural network for protein-specific de novo drug generation as a machine translation problem.
    Grechishnikova D
    Sci Rep; 2021 Jan; 11(1):321. PubMed ID: 33432013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Entangled Conditional Adversarial Autoencoder for de Novo Drug Discovery.
    Polykovskiy D; Zhebrak A; Vetrov D; Ivanenkov Y; Aladinskiy V; Mamoshina P; Bozdaganyan M; Aliper A; Zhavoronkov A; Kadurin A
    Mol Pharm; 2018 Oct; 15(10):4398-4405. PubMed ID: 30180591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep Reinforcement Learning for Multiparameter Optimization in
    Ståhl N; Falkman G; Karlsson A; Mathiason G; Boström J
    J Chem Inf Model; 2019 Jul; 59(7):3166-3176. PubMed ID: 31273995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTMol-GPT: De novo multi-target molecular generation with transformer-based generative adversarial imitation learning.
    Ai C; Yang H; Liu X; Dong R; Ding Y; Guo F
    PLoS Comput Biol; 2024 Jun; 20(6):e1012229. PubMed ID: 38924082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ChemistGA: A Chemical Synthesizable Accessible Molecular Generation Algorithm for Real-World Drug Discovery.
    Wang J; Wang X; Sun H; Wang M; Zeng Y; Jiang D; Wu Z; Liu Z; Liao B; Yao X; Hsieh CY; Cao D; Chen X; Hou T
    J Med Chem; 2022 Sep; 65(18):12482-12496. PubMed ID: 36065998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The power of deep learning to ligand-based novel drug discovery.
    Baskin II
    Expert Opin Drug Discov; 2020 Jul; 15(7):755-764. PubMed ID: 32228116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular language models: RNNs or transformer?
    Chen Y; Wang Z; Zeng X; Li Y; Li P; Ye X; Sakurai T
    Brief Funct Genomics; 2023 Jul; 22(4):392-400. PubMed ID: 37078726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo drug design based on Stack-RNN with multi-objective reward-weighted sum and reinforcement learning.
    Hu P; Zou J; Yu J; Shi S
    J Mol Model; 2023 Mar; 29(4):121. PubMed ID: 36991180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep Convolutional Generative Adversarial Network (dcGAN) Models for Screening and Design of Small Molecules Targeting Cannabinoid Receptors.
    Bian Y; Wang J; Jun JJ; Xie XQ
    Mol Pharm; 2019 Nov; 16(11):4451-4460. PubMed ID: 31589460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.